Cargando…

Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity

BACKGROUND: Influenza viruses are a major cause of morbidity and mortality around the world. More recently, a swine-origin influenza A (H1N1) virus that is spreading via human-to-human transmission has become a serious public concern. Although vaccination is the primary strategy for preventing infec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shih, Shin-Ru, Chu, Tzu-Yun, Reddy, Gadarla Randheer, Tseng, Sung-Nain, Chen, Hsiun-Ling, Tang, Wen-Fang, Wu, Ming-sian, Yeh, Jiann-Yih, Chao, Yu-Sheng, Hsu, John TA, Hsieh, Hsing-Pang, Horng, Jim-Tong
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838761/ https://www.ncbi.nlm.nih.gov/pubmed/20178582 http://dx.doi.org/10.1186/1423-0127-17-13

Ejemplares similares

Aminoluciferins Extend Firefly Luciferase Bioluminescence into the Near-Infrared and Can Be Preferred Substrates over d-Luciferin
por: Mofford, David M., et al.
Publicado: (2014)

BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-Proliferative Activity in MDR1 (P-gp170)-Mediated Multidrug-Resistant Cancer Cells
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2011)

BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML
por: Lin, W-H, et al.
Publicado: (2012)

Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer
por: Lin, Wen-Hsing, et al.
Publicado: (2014)

Luciferin Amides Enable in Vivo Bioluminescence Detection of Endogenous Fatty Acid Amide Hydrolase Activity
por: Mofford, David M., et al.
Publicado: (2015)

EHMTI-0034. Pharmacological modulation of trigemino-nociceptive stimulation pd06
por: Kröger, IL, et al.
Publicado: (2014)

Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts
por: Liu, Li, et al.
Publicado: (2012)

A Novel Aurora-A Inhibitor, BPR1K0609S1, Sensitizes Colorectal Tumor cells to 5-Fluorofracil (5-FU) Treatment
por: Shionome, Yoshimi, et al.
Publicado: (2013)

A Novel Aurora-A Inhibitor, BPR1K0609S1, Sensitizes Colorectal Tumor cells to 5-Fluorofracil (5-FU) Treatment
por: Shionome, Yoshimi, et al.
Publicado: (2013)

An Antimitotic and Antivascular Agent BPR0L075 Overcomes Multidrug Resistance and Induces Mitotic Catastrophe in Paclitaxel-Resistant Ovarian Cancer Cells
por: Wang, Xiaolei, et al.
Publicado: (2013)

EU Regulation of Nanobiocides: Challenges in Implementing the Biocidal Product Regulation (BPR)
por: Brinch, Anna, et al.
Publicado: (2016)

trans-Diacetonitriletetrakis(1H-pyrazole-κN (2))nickel(II) dinitrate
por: Chen, Chien-Hong, et al.
Publicado: (2009)

Securin Enhances the Anti-Cancer Effects of 6-Methoxy-3-(3′,4′,5′-Trimethoxy-Benzoyl)-1H-Indole (BPR0L075) in Human Colorectal Cancer Cells
por: Tseng, Ho-Hsing, et al.
Publicado: (2012)

P.0034 Covid-19 strict home confinement decreased caregivers burden of people with cognitive impairment and mild dementia
por: Sanchez-Lafuente, C. Gomez, et al.
Publicado: (2021)

In vivo and in vitro characterization of GL0034, a novel long‐acting glucagon‐like peptide‐1 receptor agonist
por: Jones, Ben, et al.
Publicado: (2022)

Observation of the Effect of Nursing BPR on Thrombolytic Efficacy and Prognosis of Patients with Cerebral Infarction Based on CT Images
por: Wang, Shaomin, et al.
Publicado: (2022)

Characterization of BPSS1521 (bprD), a Regulator of Burkholderia pseudomallei Virulence Gene Expression in the Mouse Model
por: Chirakul, Sunisa, et al.
Publicado: (2014)

WCN23-0034 A COMPARISON OF GAM-COVID-VAC (SPUTNIK V) VACCINE IMMUNOGENICITY IN HEMODIALYSIS PATIENTS AND NON-RENAL SUBJECTS
por: PARSHINA, E., et al.
Publicado: (2023)

Perturbation of the two-component signal transduction system, BprRS, results in attenuated virulence and motility defects in Burkholderia pseudomallei
por: Lazar Adler, Natalie R., et al.
Publicado: (2016)

BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor
por: Tsai, Hui‐Jen, et al.
Publicado: (2018)

Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation
por: Hsu, Yung Chang, et al.
Publicado: (2016)

Chlorido[hydridotris(pyrazol-1-yl-κN (2))borato](1H-pyrazole-κN (2))(triphenylphosphine-κP)ruthenium(II)
por: Huang, Chiung-Cheng, et al.
Publicado: (2010)

One Primer To Rule Them All: Universal Primer That Adds BBa_B0034 Ribosomal Binding Site to Any Coding Standard 10 BioBrick
por: Bryksin, Anton V., et al.
Publicado: (2014)

Genome Sequences of a Staphylococcus aureus Clinical Isolate, Strain SMA0034-04 (UGA22), from Siaya County Referral Hospital in Siaya, Kenya
por: Xie, Gary, et al.
Publicado: (2019)

(Ammine)(carbonyl)[hydridotris(pyrazol-1-yl-κN (2))borato](triphenylphosphine-κP)ruthenium(II) chloride dichloromethane disolvate
por: Hu, Ting-Chuan, et al.
Publicado: (2012)

Potent and Broad-Spectrum Bactericidal Activity of a Nanotechnologically Manipulated Novel Pyrazole
por: Alfei, Silvana, et al.
Publicado: (2022)

Novel family of bis-pyrazole coordination complexes as potent antibacterial and antifungal agents
por: Draoui, Youssef, et al.
Publicado: (2022)

Stress-Tolerant Endophytic Isolate Priestia aryabhattai BPR-9 Modulates Physio-Biochemical Mechanisms in Wheat (Triticum aestivum L.) for Enhanced Salt Tolerance
por: Shahid, Mohammad, et al.
Publicado: (2022)

0034. Changes of TLR2, TLR4, MYD88 MRNA expressions on peripheral blood mononuclear cell in severe sepsis patients during treatment with thymosin α1
por: Tang, Z, et al.
Publicado: (2014)

Synthesis and Antimicrobial Studies of Coumarin-Substituted Pyrazole Derivatives as Potent Anti-Staphylococcus aureus Agents
por: Alnufaie, Rawan, et al.
Publicado: (2020)

Molecular Modelling Studies on Pyrazole Derivatives for the Design of Potent Rearranged during Transfection Kinase Inhibitors
por: Bhujbal, Swapnil P., et al.
Publicado: (2021)

Identification of a Potent Cytotoxic Pyrazole with Anti-Breast Cancer Activity That Alters Multiple Pathways
por: Gutierrez, Denisse A., et al.
Publicado: (2022)

Discovery of Novel Tetrazoles Featuring a Pyrazole Moiety as Potent and Highly Selective Antifungal Agents
por: Chi, Xiaochen, et al.
Publicado: (2023)

(Dithiobenzoato-κ(2) S,S′)[hydridotris(pyrazol-1-yl-κN (2))borato](triphenylphosphine-κP)ruthenium(II)
por: Lin, Chia-Her, et al.
Publicado: (2008)

Azido(benzonitrile-κN)[hydridotris(pyrazol-1-yl-κN (2))borato](triphenylphosphine-κP)ruthenium(II)
por: Huang, Chiung-Cheng, et al.
Publicado: (2010)

Microwave-assisted one pot three-component synthesis of some novel pyrazole scaffolds as potent anticancer agents
por: Gomha, Sobhi M., et al.
Publicado: (2017)

Synthesis and Bioactivity Assessment of Novel Spiro Pyrazole-Oxindole Congeners Exhibiting Potent and Selective in vitro Anticancer Effects
por: Abo-Salem, Heba M., et al.
Publicado: (2020)

(Benzonitrile-κN)chlorido[hydridotris(pyrazol-1-yl-κN (2))borato](triphenylphosphine-κP)ruthenium(II) ethanol solvate
por: Tong, Hung-Chun, et al.
Publicado: (2009)

[Hydridotris(pyrazol-1-yl-κN (2))borato]bis(methylamino-κN)(triphenylphosphine-κP)ruthenium(II) chloride dichloromethane solvate monohydrate
por: Lin, Yi-Dong, et al.
Publicado: (2012)

(Benzonitrile-κN)chlorido[hydridotris(pyrazol-1-yl-κN (2))borato](triphenylphosphine-κP)ruthenium(II) ethanol solvate. Corrigendum
por: Tong, Hung-Chun, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_30t0m81l3upj5ggjt7eqgongmo